Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and has been considered a very immunogenic tumor. The treatment with radiofrequency ablation (RFA) has been established as the standard ablative therapy for early HCC, and is currently recognized as the main ablative tool for HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Adriano Carneiro, Sodergren, Mikael, Jayant, Kumar, Santa Cruz, Fernando, Spalding, Duncan, Pai, Madhava, Habib, Nagy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267689/
https://www.ncbi.nlm.nih.gov/pubmed/32536773
http://dx.doi.org/10.3748/wjg.v26.i17.2040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267689/
https://www.ncbi.nlm.nih.gov/pubmed/32536773
http://dx.doi.org/10.3748/wjg.v26.i17.2040

Ejemplares similares